Benzyl (2S,3R)-3-[2-(4-methylphenyl)ethyl]-4-oxo-1-[(3S)-3-phenylbutanoyl]azetidine-2-carboxylate
C30H31NO4 — CID 157265009
Data last refreshed: (MolForge compound catalog, from PubChem)
About Benzyl (2S,3R)-3-[2-(4-methylphenyl)ethyl]-4-oxo-1-[(3S)-3-phenylbutanoyl]azetidine-2-carboxylate
Benzyl (2S,3R)-3-[2-(4-methylphenyl)ethyl]-4-oxo-1-[(3S)-3-phenylbutanoyl]azetidine-2-carboxylate (PubChem CID 157265009) has the molecular formula C30H31NO4 and a molecular weight of 469.58 g/mol. Its IUPAC name is benzyl (2S,3R)-3-[2-(4-methylphenyl)ethyl]-4-oxo-1-[(3S)-3-phenylbutanoyl]azetidine-2-carboxylate.
Molecular Properties
| Compound Name | Benzyl (2S,3R)-3-[2-(4-methylphenyl)ethyl]-4-oxo-1-[(3S)-3-phenylbutanoyl]azetidine-2-carboxylate |
|---|---|
| PubChem CID | 157265009 |
| Molecular Formula | C30H31NO4 |
| Molecular Weight | 469.58 g/mol |
| Exact Mass | 469.23 |
| IUPAC Name | benzyl (2S,3R)-3-[2-(4-methylphenyl)ethyl]-4-oxo-1-[(3S)-3-phenylbutanoyl]azetidine-2-carboxylate |
| SMILES | Cc1ccc(CC[C@H]2C(=O)N(C(=O)C[C@H](C)c3ccccc3)[C@@H]2C(=O)OCc2ccccc2)cc1 |
| InChI | InChI=1S/C30H31NO4/c1-21-13-15-23(16-14-21)17-18-26-28(30(34)35-20-24-9-5-3-6-10-24)31(29(26)33)27(32)19-22(2)25-11-7-4-8-12-25/h3-16,22,26,28H,17-20H2,1-2H3/t22-,26+,28-/m0/s1 |
| InChIKey | JCGORENMACPDTK-MDBQKXLBSA-N |
| XLogP | 5.22 |
| TPSA | 63.68 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 469.58 |
| LogP ≤ 5 | 5.22 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157265009 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.